Purple Biotech Ltd.

NASDAQ: PPBT · Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT

Purple Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.28M -19.88M -21.76M -17.83M
Depreciation & Amortization
186K 197K 201K 231K
Stock-Based Compensation
582K 1.88M 2.41M 2.08M
Other Working Capital
-2.26M -1.06M 11K 27K
Other Non-Cash Items
-3.52M -2.39M -843K -108K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.33M 274K 3.25M 550K
Operating Cash Flow
-14.37M -19.93M -16.73M -15.07M
Capital Expenditures
n/a -3K -228K -115K
Cash Acquisitions
n/a -3.55M n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
189K 16.68M 19.82M 13.16M
Other Investing Acitivies
320K 755K 324K 359K
Investing Cash Flow
509K 13.88M 19.91M 13.41M
Debt Repayment
-183K -168K -165K -153K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.15M 4.05M -219K 1.1M
Financial Cash Flow
6.77M 5.45M 1.11M 1.51M
Net Cash Flow
-7.09M -541K 4.14M -357K
Free Cash Flow
-14.37M -19.93M -16.96M -15.19M